[{"address1": "2 Corporate Drive", "address2": "First Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 239 2030", "website": "https://www.sentibio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Senti Biosciences, Inc. operates as a clinical-stage biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (\u0093NK\u0094) cells to create CAR-NK cells outfitted with gene circuit technologies in several oncology indications with high unmet need. The company product candidates include SENTI-202, is a potentially first-in-class Logic Gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers, relapsed/refractory hematological malignancies, including Acute Myeloid Leukemia (\u0093AML\u0094); and SENTI-301A, is a multi-armed, off-the-shelf CAR-NK cell therapy for the treatment of solid tumors, and hepatocellular carcinoma (\u0093HCC\u0094). In addition, it develops the Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 630788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kanya  Rajangam M.D., Ph.D.", "age": 50, "title": "President, Head of Research & Development and Chief Medical Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 528545, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wilson  Wong Ph.D.", "title": "Scientific Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jay  Cross", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Faraz  Siddiqui", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert H. Cutler J.D.", "age": 56, "title": "Senior VP & Head of Legal Affairs", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas P. Chung", "title": "Vice President of Strategic Finance & Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dee Olomajeye Dragon", "title": "VP of People & Culture Strategy & Head of Administrative Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.25, "open": 3.29, "dayLow": 3.1512, "dayHigh": 3.36, "regularMarketPreviousClose": 3.25, "regularMarketOpen": 3.29, "regularMarketDayLow": 3.1512, "regularMarketDayHigh": 3.36, "payoutRatio": 0.0, "beta": 2.329, "forwardPE": -4.4266667, "volume": 41876, "regularMarketVolume": 41876, "averageVolume": 95770, "averageVolume10days": 427960, "averageDailyVolume10Day": 427960, "bid": 2.4, "ask": 4.13, "bidSize": 2, "askSize": 2, "marketCap": 86334608, "fiftyTwoWeekLow": 1.52, "fiftyTwoWeekHigh": 16.94, "fiftyDayAverage": 3.50982, "twoHundredDayAverage": 3.257005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 96469496, "profitMargins": 0.0, "floatShares": 9419822, "sharesOutstanding": 26004400, "sharesShort": 69452, "sharesShortPriorMonth": 39592, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0027, "heldPercentInsiders": 0.57227004, "heldPercentInstitutions": 0.2033, "shortRatio": 3.15, "shortPercentOfFloat": 0.0028, "impliedSharesOutstanding": 26004400, "bookValue": 5.311, "priceToBook": 0.62511766, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -55312000, "trailingEps": -12.03, "forwardEps": -0.75, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToEbitda": -1.913, "52WeekChange": -0.14871794, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 3.32, "targetHighPrice": 12.0, "targetLowPrice": 12.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 48612000, "totalCashPerShare": 1.869, "ebitda": -50439000, "totalDebt": 33641000, "quickRatio": 3.835, "currentRatio": 4.485, "debtToEquity": 66.281, "returnOnAssets": -0.31219, "returnOnEquity": -0.89726996, "grossProfits": -34356000, "freeCashflow": -1608125, "operatingCashflow": -41397000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNTI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.153844, "regularMarketPrice": 3.32, "shortName": "Senti Biosciences, Inc.", "longName": "Senti Biosciences, Inc.", "priceEpsCurrentYear": -1.7659575, "fiftyDayAverageChange": -0.18982005, "fiftyDayAverageChangePercent": -0.05408256, "twoHundredDayAverageChange": 0.06299496, "twoHundredDayAverageChangePercent": 0.019341376, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1746225876, "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_538838857", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1622035800000, "fiftyTwoWeekLowChange": 1.8, "fiftyTwoWeekLowChangePercent": 1.1842105, "fiftyTwoWeekRange": "1.52 - 16.94", "fiftyTwoWeekHighChange": -13.620001, "fiftyTwoWeekHighChangePercent": -0.8040142, "fiftyTwoWeekChangePercent": -14.871794, "earningsTimestamp": 1742500860, "earningsTimestampStart": 1746734460, "earningsTimestampEnd": 1747166460, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.03, "epsForward": -0.75, "epsCurrentYear": -1.88, "postMarketChangePercent": -0.602409, "postMarketPrice": 3.3, "postMarketChange": -0.02, "regularMarketChange": 0.06999993, "regularMarketDayRange": "3.1512 - 3.36", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 95770, "displayName": "Senti Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]